Related Experiment Video
Updated: Mar 26, 2026

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Components of the lectin pathway of complement activation in paediatric patients of intensive care units
Anna S Świerzko1, Agnieszka Szala-Poździej1, David C Kilpatrick2
1Laboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland.
Insights
Low mannose-binding lectin (MBL) genotypes are linked to sepsis in children. However, inherited lectin pathway deficiencies, except possibly MBL, do not predispose to sepsis; protein levels change with disease severity.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Infections are a leading cause of childhood mortality.
- The lectin pathway of complement activation plays a role in innate immunity.
- Sepsis in children, especially neonates, presents a significant clinical challenge.
Purpose of the Study:
- To investigate genetic and protein components of the lectin pathway in pediatric sepsis.
- To determine if genetic variations in lectin pathway genes predispose children to sepsis.
- To analyze changes in lectin pathway protein concentrations during sepsis.
Main Methods:
- Genotyping of lectin pathway genes (MBL, FCN1-3, MASP1/3, MASP2) and TLRs (TLR2, TLR4) in neonates and older children with sepsis and controls.
- Serum protein level analysis of MBL, ficolins, and MASP-2.
- Comparison of genetic frequencies and protein levels between sepsis patients and various control groups.
Main Results:
- Low MBL-conferring genotypes were more frequent in sepsis patients than controls.
- No significant differences in other lectin pathway or TLR gene SNPs were found.
- Sepsis was generally associated with low serum MBL and ficolin-2; neonate ficolin-1 and MASP-2 were elevated, while older children had lower ficolin-3 and MASP-2.
Conclusions:
- Inherited lectin pathway insufficiencies, except potentially MBL, do not appear to predispose to sepsis.
- Changes in lectin pathway protein concentrations likely reflect the disease course rather than predisposing factors.
- Further research into MBL's role in pediatric sepsis is warranted.
Abstract:
Infections are a major cause of childhood mortality. We investigated components of the lectin pathway of complement activation in the context of sepsis at both genetic and protein levels in neonates, infants and older children. Major components of the lectin pathway and two genes for Toll-like receptors were studied in 87 neonates with confirmed sepsis and compared with 40 babies with infections who did not develop sepsis (disease controls) and 273 infection-free neonatal controls. A second cohort comprised 47 older children with sepsis and 87 controls. Low MBL-conferring genotypes (LXA/O+O/O) were more frequent in sepsis patients than in healthy controls but no significant differences in the frequency of SNPs of other lectin pathway genes (FCN1, FCN2, FCN3, MASP1/3, MASP2) or TLR receptor genes (TLR2, TLR4) were found. One case of primary MASP-2 deficiency was found among healthy pre-terms and one neonate suffering from SIRS was heterozygous for the rare FCN1 gene mutation, +6658 G>A. Generally, sepsis was associated with low serum MBL and low ficolin-2 concentrations on admission. Among neonates, ficolin-1 and MASP-2 levels were elevated in sepsis relative to healthy, but not disease, controls. Unlike neonates, ficolin-3 and MASP-2 levels were lower in older patients than in healthy controls while no difference was found for ficolin-1. With the possible exception of MBL, inherited lectin pathway insufficiencies do not seem to predispose to sepsis, rather changes in protein concentrations reflect alterations in disease course.
Related Concept Videos
Complement System
Selectins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

